{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-009028","form_type":"8-K","ticker":"PHBI","cik":"0001435181","company_name":"Pharmagreen Biotech Inc.","filed_at":"2022-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.647031+00:00","generated_at":"2026-06-21T10:09:51.917223+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Pharmagreen issues $50K convertible note at 42.5% discount; hires Tyrell Crosby for 10M shares","bullets":["Convertible promissory note: $50,000 principal, 10% interest, due May 1, 2023; conversion price is 57.5% of average 3 lowest trading prices (42.5% discount).","Note issued to accredited investor JanBella Group LLC under Regulation D; company may prepay at 125% within 120 days, no prepayment after.","Product endorsement agreement with NFL player Tyrell Crosby: receives 10M common shares for 1.5-year term as brand ambassador for NutraMax Genomic Supplement.","Crosby also entitled to $1,000 per day plus travel expenses for appearances at company events or shows.","Company had approximately 444.8M shares outstanding prior to these issuances; potential dilution from note conversion and share issuance."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-009028","json":"https://secwatch.observer/filing/0001477932-22-009028.json","markdown":"https://secwatch.observer/filing/0001477932-22-009028.md","text":"https://secwatch.observer/filing/0001477932-22-009028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1435181/000147793222009028/0001477932-22-009028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1435181/000147793222009028/phbi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T10:09:51.917223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"943c740d2a98931eae1102a34f5a66924c0fa4b5","claim":"Pharmagreen Biotech Inc. entered into Securities Purchase Agreement with JanBella Group, LLC. valued at $50,000.","evidence_excerpt":"Pharmagreen Biotech, Inc., a (“NV”) corporation (the “Company”) and JanBella Group, LLC. (the “Investor”) have entered into a Securities Purchase Agreement dated as of November 2nd, 2022 (the “Agreement”) providing for the issuance of the Convertible Promissory Note in the principal amount of $50,000","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1435181/000147793222009028/0001477932-22-009028-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"JanBella Group, LLC."},{"label":"Value","value":"$50,000"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}